Axon Enterprise, Inc (NASDAQ:AXON) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Axon Enterprise, Inc (NASDAQ:AXON) has been given a consensus recommendation of “Moderate Buy” by the eighteen ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $722.1250.

A number of analysts have issued reports on the stock. Zacks Research upgraded shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 19th. UBS Group dropped their price target on shares of Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research note on Thursday, May 7th. Citizens Jmp reaffirmed a “market outperform” rating and issued a $700.00 price objective on shares of Axon Enterprise in a research note on Thursday, June 25th. Barclays decreased their price objective on shares of Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating for the company in a report on Friday, May 8th. Finally, Needham & Company LLC increased their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a research report on Monday, July 6th.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CRO Cameron Brooks sold 1,242 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total transaction of $621,000.00. Following the completion of the sale, the executive owned 49,710 shares of the company’s stock, valued at $24,855,000. This represents a 2.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 13,000 shares of the stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $488.45, for a total value of $6,349,850.00. Following the transaction, the president owned 169,125 shares in the company, valued at approximately $82,609,106.25. This trade represents a 7.14% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 58,989 shares of company stock worth $30,527,983 in the last 90 days. Company insiders own 4.20% of the company’s stock.

Institutional Trading of Axon Enterprise

A number of institutional investors and hedge funds have recently modified their holdings of the company. Darwin Wealth Management LLC bought a new position in Axon Enterprise in the 2nd quarter worth $37,000. Creative Financial Designs Inc. ADV bought a new stake in Axon Enterprise during the fourth quarter valued at about $28,000. Sound Income Strategies LLC grew its position in shares of Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after purchasing an additional 44 shares during the last quarter. Camelot Portfolios LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at about $30,000. Finally, AlphaCentric Advisors LLC bought a new position in shares of Axon Enterprise in the fourth quarter worth about $34,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Down 2.8%

AXON stock traded down $16.20 during mid-day trading on Friday, hitting $565.80. The stock had a trading volume of 762,731 shares, compared to its average volume of 1,119,821. Axon Enterprise has a 1-year low of $339.01 and a 1-year high of $885.91. The company has a fifty day moving average of $457.90 and a 200 day moving average of $483.77. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $45.60 billion, a price-to-earnings ratio of 227.23, a PEG ratio of 11.87 and a beta of 1.38.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.01. The business had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.90 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm’s revenue was up 33.7% on a year-over-year basis. During the same period in the previous year, the company earned $1.47 EPS. On average, equities analysts expect that Axon Enterprise will post 1.63 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.